C. David James

38.3k total citations · 6 hit papers
237 papers, 19.5k citations indexed

About

C. David James is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, C. David James has authored 237 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Molecular Biology, 114 papers in Genetics and 57 papers in Oncology. Recurrent topics in C. David James's work include Glioma Diagnosis and Treatment (112 papers), Cancer Genomics and Diagnostics (18 papers) and Epigenetics and DNA Methylation (17 papers). C. David James is often cited by papers focused on Glioma Diagnosis and Treatment (112 papers), Cancer Genomics and Diagnostics (18 papers) and Epigenetics and DNA Methylation (17 papers). C. David James collaborates with scholars based in United States, Sweden and United Kingdom. C. David James's co-authors include A. Jonas Ekstrand, V. Peter Collins, V. Peter Collins, Jann N. Sarkaria, Noriaki Sugawa, Webster K. Cavenee, Mark A. Schroeder, Robert B. Jenkins, Mitchel S. Berger and Rintaro Hashizume and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

C. David James

233 papers receiving 19.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

2008 781 citations Claudia Petritsch, Anders I. Persson et al. profile →
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

2000 529 citations C. David James et al. profile →
Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo.

1991 519 citations C. David James et al. profile →
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression

2013 489 citations Rintaro Hashizume, Nalin Gupta et al. profile →
An Overview of Meningiomas

2018 308 citations Craig Horbinski, C. David James et al. profile →
Review of gas emissions from lithium-ion battery thermal runaway failure — Considering toxic and flammable compounds

2024 92 citations C. David James et al. profile →

Peers

Countries citing papers authored by C. David James

Since Specialization

Citations

This map shows the geographic impact of C. David James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. David James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. David James more than expected).

Fields of papers citing papers by C. David James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. David James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. David James. The network helps show where C. David James may publish in the future.

Co-authorship network of co-authors of C. David James

This figure shows the co-authorship network connecting the top 25 collaborators of C. David James. A scholar is included among the top collaborators of C. David James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. David James. C. David James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma 2021 ·Brain ·Jack Shireman, Fatemeh Atashi, Gina Lee, Eunüs S. Ali, (unknown), (unknown), (unknown), Shivani Baisiwala, Jason Miska, Maciej S. Lesniak, C. David James, Roger Stupp, Priya Kumthekar, Craig Horbinski, Issam Ben‐Sahra, Atique U. Ahmed	46
2	Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity 2021 ·Proceedings of the National Academy of Sciences ·Katarzyna C. Pituch, Μαρκέλλα Ζαννίκου, (unknown), Ting Xiao, (unknown), Madina Sukhanova, Nicola Bertolino, Daniele Procissi, Christina Amidei, Craig Horbinski, Karen S. Aboody, C. David James, Maciej S. Lesniak, Irina V. Balyasnikova	20
3	Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma 2020 ·Clinical Cancer Research ·(unknown), Katarzyna C. Pituch, Hiroaki Katagi, Μαρκέλλα Ζαννίκου, (unknown), Ting Xiao, Yu Han, Adam M. Sonabend, David T. Curiel, Erin R. Bonner, Javad Nazarian, Craig Horbinski, C. David James, Amanda Saratsis, Rintaro Hashizume, Maciej S. Lesniak, Irina V. Balyasnikova	52
4	Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth 2019 ·Clinical Cancer Research ·Jonathan B. Lamano, (unknown), (unknown), Joseph D. DiDomenico, Winward Choy, Dorina Veliceasa, Daniel E. Oyon, Shayan Fakurnejad, Leonel Ampie, Kartik Kesavabhotla, Rajwant Kaur, Gurvinder Kaur, Dauren Biyashev, Dusten Unruh, Craig Horbinski, C. David James, Andrew T. Parsa, Orin Bloch	137
5	Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations 2019 ·Clinical Cancer Research ·Daniel Y. Zhang, Crismita Dmello, Li Chen, Víctor A. Arrieta, Edgar González-Buendía, J. Robert Kane, (unknown), (unknown), C. David James, Craig Horbinski, Alexandre Carpentier, Carole Desseaux, Michael Canney, Miguel Muzzio, Roger Stupp, Adam M. Sonabend	124
6	SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes 2019 ·Cancer Research ·Xiao Song, Xuechao Wan, Tianzhi Huang, Chang Zeng, Namratha Sastry, Bingli Wu, C. David James, Craig Horbinski, Ichiro Nakano, Wei Zhang, Bo Hu, Shi‐Yuan Cheng	73
7	Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas 2018 ·Clinical Cancer Research ·Dusten Unruh, Snezana Mirkov, Brian Wray, Michael Drumm, Jonathan B. Lamano, (unknown), (unknown), (unknown), Kathleen McCortney, Amanda Saratsis, Denise Scholtens, Jann N. Sarkaria, C. David James, Craig Horbinski	32
8	Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival 2017 ·Clinical Cancer Research ·Lijie Zhai, Erik Ladomersky, Kristen L. Lauing, Meijing Wu, Matthew Genet, Galina Gritsina, Balázs Győrffy, Priscilla K. Brastianos, David C. Binder, Jeffrey A. Sosman, Francis J. Giles, C. David James, Craig Horbinski, Roger Stupp, Derek A. Wainwright	144
9	BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas 2016 ·Clinical Cancer Research ·Aleksandra Olow, Sabine Mueller, Xiao-Dong Yang, Rintaro Hashizume, Justin Meyerowitz, William A. Weiss, Adam Resnick, Angela J. Waanders, Lukas J.A. Stalpers, Mitchel S. Berger, Nalin Gupta, C. David James, Claudia Petritsch, Daphne A. Haas‐Kogan	33
10	MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma 2016 ·Molecular Cancer Research ·Jonathan B. Bell, Frank Eckerdt, (unknown), (unknown), (unknown), Yingtao Bi, Ahmet Arslan, Jessica Clymer, (unknown), Stewart Goldman, Shi‐Yuan Cheng, Ichiro Nakano, Craig Horbinski, Ramana V. Davuluri, C. David James, Leonidas C. Platanias	30
11	Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model 2016 ·Molecular Cancer Therapeutics ·Gina Lee, Brenda Auffinger, Donna Guo, (unknown), (unknown), Alex L. Tobias, Jeong Yeon Kim, Fatemeh Atashi, Lingjiao Zhang, Maciej S. Lesniak, C. David James, Atique U. Ahmed	94
12	Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma 2014 ·Molecular Cancer Therapeutics ·(unknown), Dustin J. Maly, Yvan H. Chanthery, Daniel W. Sirkis, Jean L. Nakamura, Mitchel S. Berger, C. David James, Kevan M. Shokat, William A. Weiss, Anders I. Persson	23
13	Targeted Therapy for BRAFV600E Malignant Astrocytoma 2011 ·Clinical Cancer Research ·Theodore Nicolaides, Huifang Li, David A. Solomon, Sujatmi Hariono, Rintaro Hashizume, Krister J. Barkovich, Stuart N. Baker, Barbara S. Paugh, Chris Jones, Tim Forshew, Guy Hindley, John Hodgson, Jung-Sik Kim, David H. Rowitch, William A. Weiss, Todd Waldman, C. David James	113
14	Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas 2010 ·Cancer Research ·Joshua D. Schiffman, John Hodgson, Scott R. VandenBerg, Patrick Flaherty, Mei‐Yin C. Polley, Mamie Yu, Paul G. Fisher, David H. Rowitch, James M. Ford, Mitchel S. Berger, Hanlee P. Ji, David H. Gutmann, C. David James	185
15	Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma 2010 ·Cancer Research ·Bruno M. Costa, Justin S. Smith, Ying Chen, Justin Chen, Heidi Phillips, Kenneth Aldape, Giuseppe Zardo, Janice Nigro, C. David James, Jane Fridlyand, Rui Manuel Reis, (unknown)	122
16	Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts 2010 ·Cancer Research ·Karine Michaud, David A. Solomon, Eric K. Oermann, Jung-Sik Kim, (unknown), Michael D. Prados, Tomoko Ozawa, C. David James, Todd Waldman	254
17	Identification of Internalizing Human Single-Chain Antibodies Targeting Brain Tumor Sphere Cells 2010 ·Molecular Cancer Therapeutics ·Xiaodong Zhu, Scott Bidlingmaier, Rintaro Hashizume, C. David James, Mitchel S. Berger, Bin Liu	34
18	p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts 2008 ·Cancer Research ·Eduard B. Dinca, Kan Lu, Jann N. Sarkaria, Russell O. Pieper, Michael D. Prados, Daphne A. Haas‐Kogan, Scott R. VandenBerg, Mitchel S. Berger, C. David James	42
19	Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors 2008 ·Cancer Research ·Joo Mi Yi, Hsing-Chen Tsai, Sabine C. Glöckner, Steven H. Lin, Joyce E. Ohm, Hariharan Easwaran, C. David James, J Costello, Gregory J. Riggins, Charles G. Eberhart, John Laterra, Angelo L. Vescovi, Nita Ahuja, James G. Herman, Kornel E. Schuebel, Stephen B. Baylin	115
20	Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma 2007 ·Journal of Clinical Oncology ·Christopher E. Pelloski, Karla V. Ballman, Alfred Furth, Li Zhang, E. Lin, Erik P. Sulman, Krishna Bhat, J. Matthew McDonald, W.K. Alfred Yung, Howard Colman, Shiao Y. Woo, Amy B. Heimberger, Dima Suki, Michael D. Prados, Susan M. Chang, Fred G. Barker, Jan C. Buckner, C. David James, Kenneth Aldape	239

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact